Pharmacist prescribing is bringing new opportunities for patient care, but with an expanded scope of practice comes a new standard of care.
What changes when a pharmacist moves from supplying medicines to making prescribing decisions? And if a decision is questioned later, how can pharmacists set themselves up to respond effectively?
In this episode of Be Risk Ready, host Amy Minion, PDL’s Lead Pharmacist – Education and Professional Development, is joined by Peta-Ann Teague, General Practitioner, Medical Lead for James Cook University’s Pharmacist Prescribing course and founder of CPD Plus, and Scott Ames, Principal Lawyer at Meridian Lawyers.
Together, they explore the evolving professional landscape for pharmacists undertaking prescribing activities, from understanding individual scope and clinical reasoning to documentation, referral and professional boundaries.
Where does your responsibility begin and end? What happens when a patient presentation moves beyond your scope? And would your clinical record tell the full story if your decision was questioned?
Listen to Episode 5 Managing risk in prescribing practice to hear practical perspectives from both medical and legal viewpoints on navigating this significant change in pharmacy practice.
At the end of this podcast, pharmacists will be able to:
- Describe the professional responsibilities and accountability associated with prescribing practice.
- Discuss key risk management strategies that support safe and defensible prescribing behaviours and decisions.
Pharmacists may determine that this activity is suitable for inclusion on their individual learning plan.
The following information is provided to assist in self-recording the activity.
The 2016 Competency Standards addressed by this activity include: 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 2.2, 2.3, 3.1, 3.2
AJP Accredited CPD identifier number: AJP26098
This activity has been accredited for 0.5 of Group One CPD (or 0.5 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan. Accreditation expires 31/8/2028.